ESC CVD Risk Calculation
ESC CVD Risk Calculation is #97 in Medical Free in France and charting in 2 of 24 countries we track.
Updated 27 Sep 2026 · rankings refresh through the day
DeveloperESC - European Society of Cardiology
CategoryMedical
PriceFree
Released
Rating★ 4.8 (99)
Version1.4.1
Age rating4+
First seen by us
25 Sep 2026
Installs (est.)10k+ worldwide
Rating
4.8 ★
99 ratings
Measured
Best rank now
#97
Measured
ESC CVD Risk Calculation on the App Store
App details
App ID
1498801246
Publisher
ESC - European Society of Cardiology
Content rating
4+
ESC CVD Risk Calculation downloads
Worldwide, per day, and installs to date. The band is open; the exact number is free with an account.
How this is calculated
Apple publishes no download counts. iPhone downloads come from chart positions and daily rating growth per country, calibrated on Google Play install counts; lifetime installs from ratings worldwide × installs per rating. Confidence is the chance the real number is within half to double ours.
Where ESC CVD Risk Calculation's downloads come from Modelled
Last 30 days: organic search, browsing the store, features and paid ads.
Active users
All platforms, worldwide. Free with an account.
Stickiness (DAU / MAU)
how many monthly users open it on a given day
Retention · share of new users still active
Day 1
Day 7
Day 30
Time spent · per daily user
Average time spent Pro
min a day
Sessions a day Pro
Time per session Pro
min
How this is calculated
Monthly users come from lifetime installs across every store, fitted on monthly active user figures companies publish; daily users = monthly × the typical daily/monthly ratio for the category. Confidence is the chance the real number is within half to double ours.
Where it ranks now
Every top chart it appears in across 24 countries.
| Country | Charts | Rank |
|---|---|---|
| MedicalFree | #97 | |
| MedicalFree | #181 |
Apps near ESC CVD Risk Calculation on the chart
Medical Free, around #97.
Ratings
App Store, worldwide.
Rating
4.8 ★
99 ratings
Measured
Ratings
99
Measured
About ESC CVD Risk Calculation
The ESC CVD Risk Calculation App is designed for healthcare professionals. It provides calculators assessing individual cardiovascular risk. It includes calculators for primary and secondary prevention in various populations:
1. SCORE2
2. SCORE2-OP
3. SCORE2-Diabetes
4. ASCVD
5. SMART
6. SMART-REACH*
7. DIAL*
8. LIFE-CVD*
* Available online on U-Prevent (Internet connection required)
The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App.
This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance.
This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC.
The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit.
The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific content within the Application.
1. SCORE2
2. SCORE2-OP
3. SCORE2-Diabetes
4. ASCVD
5. SMART
6. SMART-REACH*
7. DIAL*
8. LIFE-CVD*
* Available online on U-Prevent (Internet connection required)
The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App.
This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance.
This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC.
The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit.
The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific content within the Application.
Latest updates
1.4.1
Performance improvements and bug fixes!